APPLICATION
ANDA083921
TYPE
ANDA
ORIGINAL APPROVAL
1984-07-31
LATEST ACTION
1998-02-17
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued
Products
ELIXOPHYLLINDiscontinued
THEOPHYLLINE 200MG · CAPSULE · ORAL
Approval history
1998-02-17Labeling · Supplement 7AP
1990-05-15Labeling · Supplement 5AP
1988-12-29Labeling · Supplement 4AP
1984-07-31OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.